Giovanni Canil

6PUBLICATIONS
22CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersPharmaceutical delivery technologiesPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Clinical Validity of Imatinib Therapeutic Drug Monitoring in a Real-World Italian Cohort of Gastrointestinal Stromal Tumors and the Role of Patients' Sex.

|Jun 29, 2026
Tissue Proteomic Signatures of BRAF-Mutated Colorectal Cancer Reveal New Insights into Aggressiveness, Immune Modulation, and Metabolic Reprogramming.

|May 23, 2024
Quantitative assessment of daratumumab in serum via intact light chain measurement using liquid chromatography-high resolution mass spectrometry: a method suitable for therapeutic drug monitoring.

Giovanni Canil, Gianmaria Miolo, Mariapaola Simula

|Jun 15, 2023
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.

Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte

|Feb 02, 2023
Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring.

Marco Orleni, Giovanni Canil, Bianca Posocco

|Jun 06, 2019
Photocytotoxic Pt(iv) complexes as prospective anticancer agents.

Giovanni Canil, Simona Braccini, Tiziano Marzo

Pageof 1

Frequent Collaborators

2 joint publications

Sara Gagno

2 joint publications

Michela Guardascione

2 joint publications

Bianca Posocco

2 joint publications

Erika Cecchin